Skip to main content

Pharmacological treatment for early and advanced stages of Parkinson’s disease: current and future strategies

Edited by Shengdi Chen and Jialin Zheng

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is manifested clinically by resting tremor, rigidity, bradykinesia and postural disability. Besides these typical motor symptoms, the occurrence of motor complications and the appearance of non-motor symptoms can be even more troublesome for patients and are often more difficult to manage.

This special issue will introduce both current and future pharmacological treatment strategies for early and later stages of PD.

Last updated on 25 February 2015

  1. The approach to early Parkinson’s disease denotes the communication of the diagnosis and important decisions, such as when and how to start treatment. Evidence based medicine and guidelines indicate which drug...

    Authors: Fabrizio Stocchi, Laura Vacca and Fabiana G Radicati
    Citation: Translational Neurodegeneration 2015 4:4